NEW YORK & PETACH TIKVA, Israel-- --Dec 11, 2012 - BrainStorm Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, is proud to announce that its positive Phase I/II ALS clinical trial data was selected as the opening presentation of the prestigious Israel Neurological Association's Annual Meeting, ... (more)
http://www.drugs.com/clinical_trials/brainstorm-s-outstanding-als-clinical-data-chosen-kick-off-israel-neurological-association-meeting-14865.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
http://www.drugs.com/clinical_trials/brainstorm-s-outstanding-als-clinical-data-chosen-kick-off-israel-neurological-association-meeting-14865.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
No comments:
Post a Comment